PP197-SUN: Lower Long-Chain N-3 Fatty Acid Status in AD: Results from a Meta-Analysis
de Wilde, M.C, Girault, E, Vellas, B, Elemans, S, Luchsinger, J.A, Yaffe, K, Swinkels, S, Sijben, J.W, Groenendijk, M, Stijnen, T
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2014)
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2014)
Get full text
Journal Article
P058: Lower choline status in AD: results from a meta-analysis
de Wilde, M.C, Vellas, B, Luchsinger, J.A, van Wijk, N, Swinkels, S, Yaffe, K, Sijben, J.W, Stijnen, T
Published in European geriatric medicine (01.09.2014)
Published in European geriatric medicine (01.09.2014)
Get full text
Journal Article
Targeting synaptic dysfunction in Alzheimer's disease: Mechanisms of action of the specific nutrient combination fortasyn connect
Sijben, J.W, van Wijk, N, de Wilde, M.C, Savelkoul, P.J, Hageman, R.J, Groenendijk, M, Wieggers, R.L, Kamphuis, P.J, Broersen, L.M
Published in European geriatric medicine (01.09.2013)
Published in European geriatric medicine (01.09.2013)
Get full text
Journal Article
A medical food Souvenaid® for AD patients can be used safely in combination with an acetylcholinesterase inhibitor in an aged rat model
van Wijk ⁎, N., de Wilde, M.C., Broersen, L.M., Kamphuis, P.J., Garthoff, J.A., Speijers, G.J.A.
Published in European journal of pharmacology (01.09.2011)
Published in European journal of pharmacology (01.09.2011)
Get full text
Journal Article